Back to today’s briefing

Story perspectives

Researcher Advances Hormone Therapy for Endometrial Cancer

1/1/2026

32 4 Full Breakdown

Summary

Story summary

Katie Colling, a doctoral candidate at the University of Iowa, researches five progestins to advance hormone therapy for endometrial cancer.
Her work contributed to a $12.8 million grant from the National Cancer Institute.
Top progestin candidates will be tested in mice before clinical trials.
Colling and Kristina Thiel stress public awareness of abnormal bleeding as an early sign of uterine cancer.

1 of 1

Story summary

Katie Colling, a doctoral candidate at the University of Iowa, researches five progestins to advance hormone therapy for endometrial cancer.
Her work contributed to a $12.8 million grant from the National Cancer Institute.
Top progestin candidates will be tested in mice before clinical trials.
Colling and Kristina Thiel stress public awareness of abnormal bleeding as an early sign of uterine cancer.